PLx Pharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of PLx Pharma generated cash of -$32,118,000, which is less than the previous year. Cash used in financing activities reached the amount of $78,966,000 last year. Net change in cash is therefore $46,943,000.
Cash Flow
| 2012 | -1.54M | 0 | 1.98M |
|---|---|---|---|
| 2013 | -2.19M | 0 | 4.59M |
| 2014 | -11.27M | 0 | 34.45M |
| 2015 | -14.59M | -26.95M | 19.74M |
| 2016 | -15.58M | 27.02M | 0 |
| 2017 | -13.30M | 11.23M | 26.41M |
| 2018 | -9.49M | -654.87K | 0 |
| 2019 | -12.65M | -230.29K | 12.64M |
| 2020 | -12.24M | -102K | 20.79M |
| 2021 | -32.11M | 95K | 78.96M |
PLXP Cash Flow Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 22.44M | 14.00M | 14.25M | 24.40M | 59.33K | 5.23M | 27.04M | 3.86M | 1.45M | 1.01M |
Operating activities | ||||||||||
Net income | -46.12M | -15.21M | -20.50M | 896.48K | -15.34M | -21.32M | -18.74M | -13.58M | -4.01M | -1.84M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 213K | 415.61K | 158.25K | 200.95K | 29.83K | 0 | 0 | 0 | 0 | 0 |
Stock-based compensation expense | 2.88M | 1.28M | 875.85K | 0 | 0 | 0 | 0 | 0 | 1.07M | 215.27K |
| Deferred income tax benefit | 2.88M | 1.28M | 875.85K | 0 | 0 | 0 | 0 | 0 | 1.07M | 215.27K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -635K | 18.68K | -449 | 1.15K | -14.30K | 0 | 0 | 0 | 0 | 0 |
Inventories | -2.31M | -143.38K | 328.41K | -524.24K | -449.38K | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 9.73M | -66.35K | 448.86K | -194.52K | -2.23M | 0 | 0 | 559.59M | 0 | 0 |
Cash generated by operating activities | -32.11M | -12.24M | -12.65M | -9.49M | -13.30M | -15.58M | -14.59M | -11.27M | -2.19M | -1.54M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | -12.97M | -30.95M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -102K | -241.73K | -654.87K | -537.56K | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 12M | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 95K | -102K | -230.29K | -654.87K | 11.23M | 27.02M | -26.95M | 0 | 0 | 0 |
Financing activities | ||||||||||
Common Stock Issued | 74.48M | 16.81M | 2.10M | 0 | 16.69M | 0 | 19.74M | 34.45M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 8.03M | 1.73M | 13.75M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -625K | -3.75M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 78.96M | 20.79M | 12.64M | 0 | 26.41M | 0 | 19.74M | 34.45M | 4.59M | 1.98M |
Net Change In Cash | 46.94M | 8.44M | -248.96K | -10.15M | 24.34M | 11.44M | -21.80M | 23.17M | 2.40M | 438.52K |
Cash at end of period | 69.39M | 22.44M | 14.00M | 14.25M | 24.40M | 16.67M | 5.23M | 27.04M | 3.86M | 1.45M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |